HealthDay News — Popular chatbots generally perform well in responding to very high-risk and very low-risk questions about suicide, according to a study published online August 26 in Psychiatric ...

HealthDay News — People who have had COVID-19 have an increased risk for developing certain new-onset type 2 inflammatory diseases of the airways, while receipt of a COVID-19 vaccine reduces the risk, ...

HealthDay News — Spironolactone does not reduce a composite outcome of cardiovascular mortality and hospitalization due to heart failure among patients receiving maintenance dialysis, according to a ...

Saroglitazar is a novel peroxisome proliferator-activated receptor alpha/gamma agonist designed to target both bile acid toxicity and liver inflammation.

COVID-19 vaccine approvals; CDC leadership in turmoil; orforglipron weight loss trial results; Ixchiq license suspended by FDA; REMS updated for Filspari.

Later in a statement Mr Zaid, with his fellow attorney Abbe Lowel, wrote that Dr Monarez “refused to rubberstamp unscientific, reckless directives” and “has neither resigned nor received notification ...

Elevated circulating trimethylamine N-oxide also linked to recommended surgical intervention for abdominal aortic aneurysms.

HBOT uses a pressurized chamber to deliver 100% oxygen, helping the lungs absorb more oxygen to support healing and fight infections, according to the FDA.

The 7-year analysis also demonstrated sustained invasive disease-free survival and distant relapse-free survival benefit.

No association seen between antibiotic exposure during pregnancy or early infancy and overall incidence of autoimmune diseases.

The SERENITY At-Home study, a double-blind, placebo-controlled 12 week trial, sought to examine the safety of administering dexmedetomidine sublingual film in an at-home setting.

The Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines Spikevax ® and mNexspike ®. The updated mRNA vaccines target the LP.8.1 variant of ...